Pharming Income Statement (2019-2025) | PHAR

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.05B0.10B43.48B-43.40B0.14B0.09B0.00B0.05B0.05B0.05B0.00B0.10B0.07B0.08B0.06B0.13B0.07B0.09B0.08B0.17B0.02B
Cost of Revenue 0.01B53.81B0.00B0.03B0.02B-0.04B0.02B0.02B0.00B0.02B0.03B0.06B0.03B0.12B0.03B0.06B0.03B0.12B0.03B0.07B-0.00B
Gross Profit 0.05B0.09B38.64B-38.50B0.05B0.08B0.05B0.05B0.05B0.09B0.06B0.07B0.05B0.11B0.07B0.08B0.07B0.16B0.02B
Operating items
Research & Development -0.01B0.03B-0.00B-0.02B-0.01B0.04B-0.01B-0.01B-0.01B-0.01B-0.02B-0.04B-0.02B-0.07B-0.02B-0.04B-0.02B-0.08B-0.02B-0.04B-0.00B
Selling, General & Administrative -0.01B0.02B-0.00B-0.02B-0.01B0.02B-0.01B-0.01B-0.01B-0.02B-0.01B-0.02B-0.01B-0.06B-0.02B-0.03B-0.02B-0.07B-0.02B-0.04B0.01B
Operating Expenses -0.01B0.04B-0.00B-0.04B-0.02B0.06B-0.02B-0.02B-0.02B-0.03B-0.03B-0.06B-0.03B-0.12B-0.03B-0.07B-0.04B-0.15B-0.04B-0.09B0.00B
Operating Income 0.02B0.04B6.27B-6.24B-0.00B0.02B0.02B0.01B-0.01B-0.01B0.00B-0.01B-0.02B-0.02B0.00B-0.01B-0.01B0.00B0.02B
EBIT 0.02B0.04B6.27B-6.24B-0.00B-0.01B0.00B0.02B0.01B-0.01B-0.01B0.00B-0.01B-0.02B-0.02B0.00B-0.01B-0.01B0.00B0.02B
Non-operating items
Other Non Operating Income -0.00B0.00B-0.00B0.00B-0.00B0.00B-0.01B-0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B0.01B0.00B-0.00B0.00B0.00B-0.00B
Non Operating Income 0.00B-0.00B0.00B-0.01B0.00B0.00B-0.00B0.00B-0.00B-0.01B0.00B
Net income details
EBT -0.03B0.00B0.00B0.02B-0.02B0.01B0.00B0.02B0.01B0.00B-0.01B0.00B-0.01B-0.02B-0.02B0.00B-0.01B-0.01B0.00B0.02B
Tax Provisions -0.00B0.01B-0.00B-0.01B-0.00B0.01B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B-0.00B-0.00B-0.00B-0.01B-0.00B
Profit After Tax 0.01B0.02B0.00B0.01B-0.00B0.01B0.00B0.02B0.01B-0.01B-0.01B0.00B-0.01B-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B0.02B
Equity Income -0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B
Net Income - Minority -0.12B-0.00B-0.00B-0.20B-0.19B-0.00B-0.19B-0.20B-0.00B-0.20B-0.20B-0.20B-0.21B-0.22B-0.21B-0.22B-0.23B-0.22B-0.21B-0.24B-0.26B
Income from Continuing Operations -0.03B-0.01B0.00B0.03B-0.02B0.02B0.00B0.02B0.01B0.01B-0.02B0.00B-0.01B-0.02B-0.02B0.01B-0.01B-0.00B0.01B0.02B
Consolidated Net Income -0.03B-0.01B0.00B0.03B-0.02B0.02B0.00B0.02B0.01B0.01B-0.02B0.00B-0.01B-0.02B-0.02B0.01B-0.01B-0.00B0.01B0.02B
Income towards Parent Company -0.12B-0.03B-0.01B-0.00B-0.17B-0.21B0.01B-0.19B-0.18B0.01B-0.20B-0.20B-0.22B-0.21B-0.23B-0.01B-0.01B0.01B-0.23B-0.01B-0.01B0.02B
Net Income towards Common Stockholders -0.12B-0.03B-0.01B-0.00B-0.17B-0.21B0.01B-0.19B-0.18B0.01B-0.20B-0.20B-0.22B-0.21B-0.23B-0.01B-0.01B0.01B-0.23B-0.01B-0.01B0.02B
Additional items
EPS (Basic) -0.00B-0.00B-0.00B-0.00B-0.01B-0.01B0.00B-0.04B-0.01B0.00B-0.01B-0.11B-0.04B-0.05B
EPS (Weighted Average and Diluted) -0.00B-0.00B-0.00B
Shares Outstanding (Weighted Average) 65.0045.0060.8113.0022.0022.0024.025.0029.0043.0021.002.005.005.00
Shares Outstanding (Diluted Average) 61.0015.5015.68
EBITDA 0.02B0.04B6.27B-6.24B-0.00B-0.01B0.00B0.02B0.01B-0.01B-0.01B0.00B-0.01B-0.02B-0.02B0.00B-0.01B-0.01B0.00B0.02B
Interest Expenses 0.02B-0.01B
Tax Rate 1.62%169,267.08%-33.37%-28.32%8.95%55.29%-2.15%-30.71%-18.05%8.23%-27.18%-25.60%-15.53%-62.03%29.16%44.01%-147.94%-9.22%